Ambarella (AMBA)
(Delayed Data from NSDQ)
$87.67 USD
-3.19 (-3.51%)
Updated Aug 17, 2022 04:00 PM ET
4-Sell of 5 4
F Value A Growth B Momentum C VGM
Income Statements
Fiscal Year end for Ambarella, Inc falls in the month of January .
All items in Millions except EPS data.
1/31/22 | 1/31/21 | 1/31/20 | 1/31/19 | 1/31/18 | |
---|---|---|---|---|---|
Sales | 332 | 223 | 229 | 228 | 295 |
Cost Of Goods | 124 | 87 | 96 | 90 | 108 |
Gross Profit | 208 | 136 | 133 | 138 | 188 |
Selling & Adminstrative & Depr. & Amort Expenses | 238 | 197 | 182 | 179 | 163 |
Income After Depreciation & Amortization | -30 | -61 | -50 | -40 | 24 |
Non-Operating Income | 1 | 4 | 8 | 6 | 1 |
Interest Expense | 0 | 0 | 0 | 0 | 0 |
Pretax Income | -29 | -57 | -42 | -35 | 26 |
Income Taxes | -2 | 2 | 3 | -4 | 7 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | -26 | -60 | -45 | -30 | 19 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | -26 | -60 | -45 | -30 | 19 |
Depreciation Footnote | 1/31/22 | 1/31/21 | 1/31/20 | 1/31/19 | 1/31/18 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | -15 | -48 | -39 | -34 | 29 |
Depreciation & Amortization (Cash Flow) | 15 | 13 | 11 | 7 | 5 |
Income After Depreciation & Amortization | -30 | -61 | -50 | -40 | 24 |
Earnings Per Share Data | 1/31/22 | 1/31/21 | 1/31/20 | 1/31/19 | 1/31/18 |
---|---|---|---|---|---|
Average Shares | 36.58 | 34.68 | 33.08 | 32.71 | 34.58 |
Diluted EPS Before Non-Recurring Items | -0.79 | -1.69 | -1.33 | -1.11 | 0.55 |
Diluted Net EPS (GAAP) | -0.72 | -1.72 | -1.35 | -0.93 | 0.55 |
Fiscal Year end for Ambarella, Inc falls in the month of January .
All items in Millions except EPS data.
7/31/22 | 4/30/22 | 1/31/22 | 10/31/21 | 7/31/21 | |
---|---|---|---|---|---|
Sales | NA | 90.31 | 90.23 | 92.17 | 79.33 |
Cost Of Goods | NA | 33.76 | 32.91 | 34.54 | 29.91 |
Gross Profit | NA | 56.55 | 57.32 | 57.63 | 49.42 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 67.05 | 69.66 | 58.84 | 55.38 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | -10.50 | -12.34 | -1.21 | -5.96 |
Non-Operating Income | NA | 0.09 | -0.22 | 0.41 | 0.22 |
Interest Expense | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Pretax Income | NA | -10.41 | -12.55 | -0.80 | -5.74 |
Income Taxes | NA | 0.41 | -3.36 | -1.56 | 1.41 |
Minority Interest | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | NA | -10.82 | -9.19 | 0.76 | -7.16 |
Extras & Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | NA | -10.82 | -9.19 | 0.76 | -7.16 |
Earnings Per Share Data | 7/31/22 | 4/30/22 | 1/31/22 | 10/31/21 | 7/31/21 |
---|---|---|---|---|---|
Average Shares | NA | 37.72 | 37.13 | 39.05 | 36.44 |
Diluted EPS Before Non-Recurring Items | NA | -0.27 | -0.29 | 0.01 | -0.18 |
Diluted Net EPS (GAAP) | NA | -0.29 | -0.24 | 0.02 | -0.20 |